US FDA expands use of Regeneron's cholesterol drug in young children
Go back to US FDA expands use of Regeneron's cholesterol drug in young children| Regeneron (NASDAQ: REGN) | Delayed: 852.03 +28.21 (3.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $823.82 | 52 Week High | $592.36 | |||
| Open | $826.24 | 52 Week Low | $325.35 | |||
| Day High | $854.49 | P/E | 223.63 | |||
| Day Low | $825.77 | EPS | $3.81 | |||
| Volume | 749,359 | |||||
